To assess the clinical effect of radium 223 (Ra223) in patients with progressive symptomatic bone metastases on a background of metastatic castrate resistant prostate cancer (mCRPC).
Citations
Altmetric:
Abstract
Authors
Affiliation
Description
Date
2016
Publisher
Collections
Keywords
Type
Article
Citation
To assess the clinical effect of radium 223 (Ra223) in patients with progressive symptomatic bone metastases on a background of metastatic castrate resistant prostate cancer (mCRPC). 2016, 34(2):347-7 J Clin Oncol